Skip to main content

Advertisement

Log in

IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Interleukin-17 (IL-17) is a proinflammatory cytokine that is expressed in the synovium T cells of rheumatoid arthritis (RA). This cytokine is implicated in the inflammation and destruction of the joint. However, the role of IL-17 on the production of vascular endothelial factor (VEGF) important to synovial proliferation has still not been identified. In this study, we investigated the effect on cultured rheumatoid fibroblast-like synoviocytes (FLS) of the IL-17 on the production and expression of VEGF, which play an important role in angiogenesis in rheumatoid synovium. IL-17 increased the production of VEGF dose dependently and the mRNA expression of VEGF. These results suggest that IL-17 might influence angiogenesis in RA by up-regulating the expression of VEGF in rheumatoid FLS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Koch AE (1998) Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum 41:951–962

    Article  PubMed  Google Scholar 

  2. Walsh DA (1999) Angiogenesis and arthritis. Rheumatology 38:103–112

    Article  PubMed  Google Scholar 

  3. Klagsbrun M, D’Amore PA (1991) Regulators of angiogenesis. Annu Rev Physiol 53:217–239

    Article  PubMed  Google Scholar 

  4. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029–1039

    PubMed  Google Scholar 

  5. Conn G, Soderman DD, Schaeffer MT, Wile M, Hatcher VB, Thomas KA (1990) Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci USA 87:1323–1327

    PubMed  Google Scholar 

  6. Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B et al (1994) Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180:341–346

    Article  PubMed  Google Scholar 

  7. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL et al (1994) Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152:4149–4156

    PubMed  Google Scholar 

  8. Nagashima M, Yoshino S, Ishiwata T, Asano G (1995) Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 22:1624–1630

    PubMed  Google Scholar 

  9. Jackson JR, Minton JA, Ho ML, Wei N, Winkler JD (1997) Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1β. J Rheumatol 24:1253–1259

    PubMed  Google Scholar 

  10. Berse B, Hunt JA, Diegel RJ, Morganelli P, Yeo K, Brown F et al (1999) Hypoxia augments cytokine (transforming growth factor-β [TGF-β] and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol 115:176–182

    Article  PubMed  Google Scholar 

  11. Ikeda E, Achen MG, Breier G, Risau W (1995) Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 270:19761–19766

    Article  PubMed  Google Scholar 

  12. Ben-Av P, Crofford LJ, Wilder RL, Hla T (1995) Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 372:83–87

    Article  PubMed  Google Scholar 

  13. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271:736–741

    PubMed  Google Scholar 

  14. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O et al (1994) Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J Biol Chem 269:6271–6274

    PubMed  Google Scholar 

  15. Paleolog EM, Young S, Stark AC, McCloskey RV, Feldmann M, Maini RN (1998) Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor α and interleukin-1 in rheumatoid arthritis. Arthritis Rheum 41:1258–1265

    Article  PubMed  Google Scholar 

  16. Cho CS, Cho ML, Min SY, Kim WU, Min DJ, Lee SS et al (2000) CD40 engagement on synovial fibroblast up-regulates production of vascular endothelial growth factor. J Immunol 164:5055–5061

    PubMed  Google Scholar 

  17. Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK et al (1995) Human IL-17: a novel cytokine derived from T cells. J Immunol 155:5483–5486

    PubMed  Google Scholar 

  18. Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C et al (1996) T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183:2593–2603

    Article  PubMed  Google Scholar 

  19. Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR et al (1995) Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3:811–821

    Article  PubMed  Google Scholar 

  20. Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M et al (1998) IL-17 stimulates the production and expression of proinflammatory cytokines, IL-1β and TNF-α by human macrophages. J Immunol 160:3513–3521

    PubMed  Google Scholar 

  21. Kurusawa K, Hirose K, Sano H, Endo H, Shinkai H, Nawata Y et al (2000) Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 43:2455–2463

    Article  PubMed  Google Scholar 

  22. Matsumoto K, Kanmatsuse K (2002) Increased urinary excretion of interleukin-17 in nephrotic patients. Nephron 91:243–249

    Article  PubMed  Google Scholar 

  23. Wong CK, Ho CY, Li EK, Lam CW (2000) Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9:589–593

    Article  PubMed  Google Scholar 

  24. Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L et al (1999) Human interleukin-17: a T cell derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42:963–970

    Article  PubMed  Google Scholar 

  25. Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H et al (2000) High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 164:2832–2838

    PubMed  Google Scholar 

  26. Chabaud M, Fossiez F, Taupin JL, Miossec P (1998) Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol 161:409–414

    PubMed  Google Scholar 

  27. Chabaud M, Lubberts E, Joosten L, van den Berg W, Miossec P (2001) IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res 3:168–177

    Article  PubMed  Google Scholar 

  28. Lubberts E, Joosten LAB, van de Loo FAJ, van den Bersselaar LA, van den Berg WB (2000) Reduction of interleukin-17 induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4. Arthritis Rheum 43:1300–1306

    Article  PubMed  Google Scholar 

  29. Martel-Pelletier J, Mineau F, Jovanovic D, Di Battista JA, Pelletier JP (1999) Mitogen-activated protein kinase and nuclear factor κB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated protein kinase (MAPKAPK). Arthritis Rheum 42:2399–2409

    Article  PubMed  Google Scholar 

  30. Lubberts E, van den Bersselaar L, Oppers-Wlagreen B, Schwarzenberger P, Coenen-de Roo CJJ, Kolls JK et al (2003) IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-κB ligand/osteoprotegerin balance. J Immunol 170:2655–2662

    PubMed  Google Scholar 

  31. Lubberts E, Joosten LAB, Oppers-Walgreen B, van den Bersselaar L, Chenen-de Roo CJJ, Kolls JK et al (2001) IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol 167:1004–1013

    PubMed  Google Scholar 

  32. Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA et al (2004) Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50:650–659

    Article  PubMed  Google Scholar 

  33. Nakae S, Nambu A, Sudo K, Iwakura Y (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171:6173–6177

    PubMed  Google Scholar 

  34. Kim JM, Ho SH, Hahn W, Jeong JG, Park EJ, Lee HJ et al (2003) Electro-gene therapy of collagen-induced arthritis by using an expression plasmid for the soluble p75 tumor necrosis factor receptor-Fc fusion protein. Gene Ther 10:1216–1224

    Article  PubMed  Google Scholar 

  35. Kato T, Furumoto H, Ogura T, Onishi Y, Irahara M, Yamano S et al (2002) Expression of IL-17 mRNA in ovarian cancer. Biochem Biophys Res Commun 282:735–738

    Article  Google Scholar 

  36. Tartour E, Fowwiez F, Joyeux I, Galinha A, Gey A, Claret E et al (1999) Interleukin 17, a T-cell-derived cytokine, promotes tumorgenicity of human cervical tumors in nude mice. Cancer Res 59:3698–3704

    PubMed  Google Scholar 

  37. Page F, Vives V, Stautes-Fridman C, Fossiez F, Berger A, Cugnenc PH et al (1999) Control of tumor development by intratumoral cytokines. Immunol Lett 68:135–139

    Article  PubMed  Google Scholar 

  38. Numasaki M, Fukushi J, Ono M, Narula SK, Zavodny PJ, Kudo T et al (2003) Interleukin-17 promotes angiogenesis and tumor growth. Blood 101:2620–2627

    Article  PubMed  Google Scholar 

  39. Chabaud M, Fossiez F, Taupin JL, Miossec P (1998) Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokine. J Immunol 161:409–414

    PubMed  Google Scholar 

  40. Katz Y, Nadiv O, Beer Y (2001) Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukin 1, 6, and 8 in skin and synovial fibroblasts: a possible role as a “fine-tuning cytokine” in inflammation process. Arthritis Rheum 44:2176–2184

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a project grant from the Supported by grants from the Pusan National University Hospital Institute

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. I. Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ryu, S., Lee, J.H. & Kim, S.I. IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes. Clin Rheumatol 25, 16–20 (2006). https://doi.org/10.1007/s10067-005-1081-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-005-1081-1

Keywords

Navigation